170 related articles for article (PubMed ID: 1348094)
21. Lethal presentation of neurofibromatosis and Noonan syndrome.
Prada CE; Zarate YA; Hagenbuch S; Lovell A; Schorry EK; Hopkin RJ
Am J Med Genet A; 2011 Jun; 155A(6):1360-6. PubMed ID: 21567923
[TBL] [Abstract][Full Text] [Related]
22. Multiple spinal nerve enlargement and SOS1 mutation: Further evidence of overlap between neurofibromatosis type 1 and Noonan phenotype.
Santoro C; Giugliano T; Melone MAB; Cirillo M; Schettino C; Bernardo P; Cirillo G; Perrotta S; Piluso G
Clin Genet; 2018 Jan; 93(1):138-143. PubMed ID: 28456002
[TBL] [Abstract][Full Text] [Related]
23. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.
Yapijakis C; Pachis N; Voumvourakis C
Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455
[TBL] [Abstract][Full Text] [Related]
24. Watson syndrome: is it a subtype of type 1 neurofibromatosis?
Allanson JE; Upadhyaya M; Watson GH; Partington M; MacKenzie A; Lahey D; MacLeod H; Sarfarazi M; Broadhead W; Harper PS
J Med Genet; 1991 Nov; 28(11):752-6. PubMed ID: 1770531
[TBL] [Abstract][Full Text] [Related]
25. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
[TBL] [Abstract][Full Text] [Related]
26. Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.
Tassabehji M; Strachan T; Sharland M; Colley A; Donnai D; Harris R; Thakker N
Am J Hum Genet; 1993 Jul; 53(1):90-5. PubMed ID: 8317503
[TBL] [Abstract][Full Text] [Related]
27. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome.
Bahuau M; Houdayer C; Assouline B; Blanchet-Bardon C; Le Merrer M; Lyonnet S; Giraud S; Récan D; Lakhdar H; Vidaud M; Vidaud D
Am J Med Genet; 1998 Jan; 75(3):265-72. PubMed ID: 9475595
[TBL] [Abstract][Full Text] [Related]
28. Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect.
Takano T; Kawashima T; Yamanouchi Y; Kitayama K; Baba T; Ueno K; Hamaguchi H
Hum Genet; 1992 May; 89(3):281-6. PubMed ID: 1351032
[TBL] [Abstract][Full Text] [Related]
29. Neurofibromatosis-Noonan syndrome and acute lymphoblastic leukemia: a report of two cases.
Klopfenstein KJ; Sommer A; Ruymann FB
J Pediatr Hematol Oncol; 1999; 21(2):158-60. PubMed ID: 10206464
[TBL] [Abstract][Full Text] [Related]
30. Genetics of neurofibromatosis 1 and the NF1 gene.
Viskochil D
J Child Neurol; 2002 Aug; 17(8):562-70; discussion 571-2, 646-51. PubMed ID: 12403554
[TBL] [Abstract][Full Text] [Related]
31. Two neurofibromatosis type 1 cases associated with rhabdomyosarcoma of bladder, one with a large deletion in the NF1 gene.
Oguzkan S; Terzi YK; Güler E; Derbent M; Agras PI; Saatci U; Ayter S
Cancer Genet Cytogenet; 2006 Jan; 164(2):159-63. PubMed ID: 16434322
[TBL] [Abstract][Full Text] [Related]
32. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants.
Johnston JJ; van der Smagt JJ; Rosenfeld JA; Pagnamenta AT; Alswaid A; Baker EH; Blair E; Borck G; Brinkmann J; Craigen W; Dung VC; Emrick L; Everman DB; van Gassen KL; Gulsuner S; Harr MH; Jain M; Kuechler A; Leppig KA; McDonald-McGinn DM; Can NTB; Peleg A; Roeder ER; Rogers RC; Sagi-Dain L; Sapp JC; Schäffer AA; Schanze D; Stewart H; Taylor JC; Verbeek NE; Walkiewicz MA; Zackai EH; Zweier C; ; Zenker M; Lee B; Biesecker LG
Genet Med; 2018 Oct; 20(10):1175-1185. PubMed ID: 29469822
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromatosis-Noonan syndrome.
Buehning L; Curry CJ
Pediatr Dermatol; 1995 Sep; 12(3):267-71. PubMed ID: 7501563
[TBL] [Abstract][Full Text] [Related]
34. Progressive hydrocephalus in two members of a family with autosomal dominant Noonan phenotype.
Henn W; Reichert H; Nienhaus H; Zankl M; Lindinger A; Hoffmann W; Zang KD
Clin Dysmorphol; 1997 Apr; 6(2):153-6. PubMed ID: 9134296
[TBL] [Abstract][Full Text] [Related]
35. The neurofibromatosis-Noonan syndrome.
Opitz JM; Weaver DD
Am J Med Genet; 1985 Jul; 21(3):477-90. PubMed ID: 3927726
[No Abstract] [Full Text] [Related]
36. Patient with a neurofibromatosis type 1 mutation but a clinical diagnosis of Noonan syndrome.
Croonen EA; Yntema HG; van Minkelen R; van den Ouweland AMW; van der Burgt I
Clin Dysmorphol; 2012 Oct; 21(4):212-214. PubMed ID: 22664660
[No Abstract] [Full Text] [Related]
37. Two independent de novo mutations as a cause for neurofibromatosis type 1 and Noonan syndrome in a single family.
Pasmant E; Amiel J; Rodriguez D; Vidaud M; Vidaud D; Parfait B
Am J Med Genet A; 2012 Sep; 158A(9):2290-1. PubMed ID: 22847776
[TBL] [Abstract][Full Text] [Related]
38. Familial neurofibromatosis type 1: clinical experience with DNA testing.
Hofman KJ; Boehm CD
J Pediatr; 1992 Mar; 120(3):394-8. PubMed ID: 1347082
[TBL] [Abstract][Full Text] [Related]
39. The gene for von Recklinghausen neurofibromatosis (NF1) maps to the pericentromeric region of chromosome 17 in Chinese families.
Xu WM; Cheng XF; Hong LS; Liu LZ; Bao Y; He RG; Zhou XJ; Shen ZZ; Qui WQ; Ponder B
Genomics; 1991 Aug; 10(4):1090-2. PubMed ID: 1916815
[TBL] [Abstract][Full Text] [Related]
40. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway.
Reig I; Boixeda P; Fleta B; Morenoc C; Gámez L; Truchuelo M
Dermatol Online J; 2011 Apr; 17(4):4. PubMed ID: 21549079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
